脑利钠肽在心房颤动导管消融治疗中的应用被引量：1

Application of plasma brain natriuretic peptide measurement in radiofrequency catheter ablation for atrial fibrillation

下载PDF

导出

摘要脑利钠肽（Btypenatriureticpeptide，BNP）是1988年日本学者Sudoh等首先从猪脑中分离出来的，是由心肌细胞合成的具有生物学活性的天然激素，主要存在于心房和心室。心肌细胞分泌的BNP先以108个氨基酸组成的前体形式存在，再在活化酶的作用下裂解为由76个氨基酸组成的无活性的直线多肽和32个氨基酸组成的活性环状多肽，释放入血循环，分别被称为N末端BNP前体（NT—proBNP）和BNP。BNP不仅有利钠、利尿、降血压以及松弛平滑肌的作用，

作者李莹莹

机构地区卫生部北京医院心内科

出处《中国心血管杂志》 2012年第4期312-313,共2页 Chinese Journal of Cardiovascular Medicine

关键词利钠肽脑心房颤动导管射频消融 Natriuretie peptide, brain Atrial fibrillation Radiofrequency Catheter ablation

分类号 R541.75 [医药卫生—心血管疾病]

引文网络
相关文献

参考文献14

1Sudoh T, Kangawa K, Minamino N, et al. A new natriuretic peptide in porcine brain. Nature, 1988, 332: 78-81.
2孙玉发,范利,李小鹰.氨基末端脑钠肽前体与急性心肌梗死的研究进展[J].中华老年医学杂志,2011,30(10):879-882. 被引量：18
3Haissaguerre M, Jais P, Shahd C, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med, 1998, 339: 659-666.
4Yamada T, Murakami Y, Okada T, et al. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation. Europace, 2007, 9 : 770-774.
5Kurosaki K, Tada H, Hashimoto T, et al. Plasma natriuretic peptide concentrations as a predictor for successful catheter ablation in patients with drug-refractory atrial fibrillation. Circ J, 2007, 71: 313-320.
6Degener S,Pattberg SV, Feuersenger H, et al. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation. J Interv Card Electrophysiol, 2011, 30: 217-225.
7Shin DI, Deneke T, Gorr E, et al. Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels, 2009, 9: 241-246.
8Gould PA, Gula LJ, Bhayana V, et al. Characterization of cardiac brain natriuretie peptide release in patients with paroxysmal atrial fibrillation undergoing left atrial ablation. Circ Arrhythm Eleetrophysiol, 2010, 3: 18-23.
9Sacher F, Corcuff JB, Schraub P, et al. Chronic atrial fibrillation ablation impact on endocrine and mechanical cardiac functions. Eur Heart J, 2008, 29: 1290-1295.
10Mohanty S, Mohanty PI Di Biase L, et al. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure- outcome in atrial fibrillation patients undergoing catheter ablation. J Cardiovasc Electrophysiol, 2011,22 : 858-865.

二级参考文献21

1Yan W,Wu F, Morser J, et al. Corin, a transmembrane cardiac serine protease, acts as a pro- atrial natriuretic peptide-converting enzyme. Proc Natl Acad Sci USA, 2000,97~8525-8529.
2Schellenberger U,O'Rear J, Guzzetta A, et al. The precursor to B-type natriuretic peptide is an O-linked glyco-protein. Arch Biochem Biophys, 2006, 451: 160-166.
3Martinez-Rumayor A, Richards AM, Burnett JC, et al. Biology of the natriuretic peptides. Am J Cardiol, 2008, 101: 3-8.
4Azzazy HM,Christenson RH, Duh SH. Stability of B-type natriuretic peptide (BNP) in whole blood and plasma stored under different conditions when measured with the Biosite Triage or Beckman-Coulter Access systems. Clin Chim Acta, 2007, 384 : 176- 178.
5Casco VH, Veinot JP, de Bold MLK, et al. Natriuretic peptide system gene expression in human coronary arteries. J Histochem Cytochem, 2002,50: 799-809.
6Barbato E, Rubattu S, Bartunek J, et al. Human coronary atherosclerosis modulates cardiac natriuretic peptide release. Atherosclerosis, 2009 ,206: 258-264.
7Shuichi T, Satoru S,Takeski B, et al. Predictors of left ventricular remodeling in patients with acute myocardial infarction participating in cardiac rehabilitation. Circ J, 2004,689 : 214-219.
8Weber M, Kleine C, Keil E, et al. Release pattern of N-terminal pro B-type natriuretic peptide (NT- proBNP) in acute coronary syndromes. Clin Res Cardiol, 2006, 95:1-11.
9Omland T,de Lemos JA. Amino-terminal pro-B type natriuretic peptides in stable and unstable ischemic heart disease. Am J Cardiol, 2008, 101 : 61-66.
10Ferraro S, Lupi A, Marano G, et al. Different patterns of NT-proBNP secretion in acute coronary syndromes. Clinica Chimica Acta, 2009, 402:176 181.